K-RAS GLY-12 Mutant Protein

Preferred Label : K-RAS GLY-12 Mutant Protein;

NCIt definition : A synthetic form of the K-ras protein containing any one of a number of point mutations at position 12 which is normally occupied by glycine (GLY). Vaccines using mutant K-ras proteins may be used in the immunotherapy of various cancers that express mutated K-ras proteins. (NCI04);

NSC code : 676841;

Details

Origin ID

C29137;

UMLS CUI

C1517634;

Semantic type(s)
- Amino Acid, Peptide, or Protein [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
chemical_or_drug_affects_cell_type_or_tissue
- Cytotoxic T-Lymphocyte [NCIt concept]
chemical_or_drug_has_mechanism_of_action
- Antigen Sensitization [NCIt concept]
chemical_or_drug_has_physiologic_effect
- Immunopotentiation [NCIt concept]
- T-Cell Activation [NCIt concept]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients